These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 31614473)
21. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. Xia D; Wang P; Chen J; Wang S; Jiang H Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619 [TBL] [Abstract][Full Text] [Related]
22. Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action. Jhang JF; Kuo HC Toxins (Basel); 2016 Apr; 8(4):120. PubMed ID: 27110822 [TBL] [Abstract][Full Text] [Related]
23. Role of alpha1-blockers in chronic prostatitis syndromes. Nickel JC BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680 [TBL] [Abstract][Full Text] [Related]
24. Chronic prostatitis/chronic pelvic pain syndrome: is there a role for local drug infiltration therapy? El-Hakim A J Endourol; 2004 Apr; 18(3):227-31. PubMed ID: 15225385 [TBL] [Abstract][Full Text] [Related]
25. Astaxanthin alleviates chronic prostatitis/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine. Liu YF; Xie WJ; Xi P; Zhang ZC; Chen R; Fu SQ; Lei KY; Liu J; Cheng XF; Nie YC; Yang XR; Ma M; Sun T; Gong BB Phytomedicine; 2024 Jan; 123():155249. PubMed ID: 38056144 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats. Zhang K; Zeng X; Chen Y; Zhao R; Wang H; Wu J BMC Complement Altern Med; 2017 Jan; 17(1):75. PubMed ID: 28122556 [TBL] [Abstract][Full Text] [Related]
27. A review of botulinum toxin use for chronic pelvic pain syndrome. Gottsch HP; Yang CC; Berger RE Curr Urol Rep; 2010 Jul; 11(4):265-70. PubMed ID: 20446070 [TBL] [Abstract][Full Text] [Related]
30. Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia-A Spotlight in Reality. Hsu YC; Wang HJ; Chuang YC Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128942 [TBL] [Abstract][Full Text] [Related]
31. The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel. Parsons BA; Goonewardene S; Dabestani S; Pacheco-Figueiredo L; Yuan Y; Zumstein V; Cottrell AM; Borovicka J; Dinis-Oliveira P; Berghmans B; Elneil S; Hughes J; Messelink BEJ; de C Williams AC; Baranowski AP; Engeler DS Eur Urol Focus; 2022 Jan; 8(1):320-338. PubMed ID: 33526405 [TBL] [Abstract][Full Text] [Related]
32. Effect of Botulinum Toxin A on Bladder Pain-Molecular Evidence and Animal Studies. Yeh TC; Chen PC; Su YR; Kuo HC Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32028597 [TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial. Choe HS; Lee SJ; Han CH; Shim BS; Cho YH J Infect Chemother; 2014 Jan; 20(1):20-5. PubMed ID: 24462419 [TBL] [Abstract][Full Text] [Related]
34. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591 [TBL] [Abstract][Full Text] [Related]
35. Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome. Qi X; Han L; Liu X; Zhi J; Zhao B; Chen D; Yu F; Zhou X Urology; 2012 Dec; 80(6):1389.e9-15. PubMed ID: 23017785 [TBL] [Abstract][Full Text] [Related]
36. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis. Jhang JF; Jiang YH; Kuo HC Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497 [TBL] [Abstract][Full Text] [Related]
37. Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what's next? Appiya Santharam M; Khan FU; Naveed M; Ali U; Ahsan MZ; Khongorzul P; Shoaib RM; Ihsan AU Eur J Pharmacol; 2019 Aug; 857():172429. PubMed ID: 31170381 [TBL] [Abstract][Full Text] [Related]